1 Study Coverage

• 1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered: Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue in 2019
• 1.4 Market by Type
  • 1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type
  • 1.4.2 Plain Old Balloon Angioplasty (POBA)
  • 1.4.3 Percutaneous Transluminal Angioplasty (PTA)
• 1.5 Market by Application
  • 1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application
  • 1.5.2 Drug-Eluting Balloons
  • 1.5.3 Drug-Eluting Stents
• 1.6 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Peripheral Intervention Drug-Eluting Devices Industry
    • 1.6.1.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Peripheral Intervention Drug-Eluting Devices Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Estimates and Forecasts
  • 2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026
  • 2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026
  • 2.1.3 Global Peripheral Intervention Drug-Eluting Devices Production Estimates and Forecasts 2015-2026
• 2.2 Global Peripheral Intervention Drug-Eluting Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.3.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution
• 2.4 Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products
• 2.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

• 3.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity
  • 3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)
  • 3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production (2015-2020)
  • 3.1.3 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Production
• 3.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue
  • 3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2015-2020)
  • 3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)
  • 3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019
• 3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Peripheral Intervention Drug-Eluting Devices Production by Regions

• 4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Facts & Figures by Regions
  • 4.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Production (2015-2020)
  • 4.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2015-2020)
• 4.2 North America
  • 4.2.1 North America Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.3 Europe
  • 4.3.1 Europe Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.4 China
  • 4.4.1 China Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.4.3 Key Players in China
  • 4.4.4 China Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)
• 4.5 Japan
  • 4.5.1 Japan Peripheral Intervention Drug-Eluting Devices Production (2015-2020)
  • 4.5.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

5 Peripheral Intervention Drug-Eluting Devices Consumption by Region

• 5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption
  • 5.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption (2015-2020)
  • 5.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)
• 5.2 North America
  • 5.2.1 North America Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.2.2 North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.2.3 U.S.
  • 5.2.4 Canada
• 5.3 Europe
  • 5.3.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 U.K.
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.4.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Taiwan
  • 5.4.9 Indonesia
  • 5.4.10 Thailand
  • 5.4.11 Malaysia
  • 5.4.12 Philippines
  • 5.4.13 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.5.2 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Country
  • 5.5.3 Mexico
  • 5.5.3 Brazil
  • 5.5.3 Argentina
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application
  • 5.6.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 Saudi Arabia
  • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

• 6.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)
  • 6.1.1 Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020)
  • 6.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)
  • 6.1.3 Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)
• 6.2 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2021-2026)
  • 6.2.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026)
  • 6.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)
  • 6.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)
• 6.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

• 7.2.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)
• 7.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

• 8.1 Medtronic plc
  • 8.1.1 Medtronic plc Corporation Information
  • 8.1.2 Medtronic plc Overview and Its Total Revenue
  • 8.1.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.1.4 Medtronic plc Product Description
  • 8.1.5 Medtronic plc Recent Development
• 8.2 Boston Scientific Corporation
  • 8.2.1 Boston Scientific Corporation Corporation Information
  • 8.2.2 Boston Scientific Corporation Overview and Its Total Revenue
  • 8.2.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.2.4 Boston Scientific Corporation Product Description
  • 8.2.5 Boston Scientific Corporation Recent Development
• 8.3 Abbott Laboratories
  • 8.3.1 Abbott Laboratories Corporation Information
  • 8.3.2 Abbott Laboratories Overview and Its Total Revenue
  • 8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.3.4 Abbott Laboratories Product Description
  • 8.3.5 Abbott Laboratories Recent Development
• 8.4 Cardinal Health
  • 8.4.1 Cardinal Health Corporation Information
  • 8.4.2 Cardinal Health Overview and Its Total Revenue
  • 8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.4.4 Cardinal Health Product Description
  • 8.4.5 Cardinal Health Recent Development
• 8.5 B. Braun Melsungen AG
  • 8.5.1 B. Braun Melsungen AG Corporation Information
  • 8.5.2 B. Braun Melsungen AG Overview and Its Total Revenue
  • 8.5.3 B. Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.5.4 B. Braun Melsungen AG Product Description
  • 8.5.5 B. Braun Melsungen AG Recent Development
• 8.6 Biosensors International Group Ltd.
  • 8.6.1 Biosensors International Group Ltd. Corporation Information
  • 8.6.2 Biosensors International Group Ltd. Overview and Its Total Revenue
  • 8.6.3 Biosensors International Group Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.6.4 Biosensors International Group Ltd. Product Description
  • 8.6.5 Biosensors International Group Ltd. Recent Development
• 8.7 C.R. Bard, Inc.
  • 8.7.1 C.R. Bard, Inc. Corporation Information
  • 8.7.2 C.R. Bard, Inc. Overview and Its Total Revenue
  • 8.7.3 C.R. Bard, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.7.4 C.R. Bard, Inc. Product Description
  • 8.7.5 C.R. Bard, Inc. Recent Development
• 8.8 Abbott
  • 8.8.1 Abbott Corporation Information
  • 8.8.2 Abbott Overview and Its Total Revenue
  • 8.8.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.8.4 Abbott Product Description
  • 8.8.5 Abbott Recent Development
• 8.9 The Lubrizol Corporation
  • 8.9.1 The Lubrizol Corporation Corporation Information
  • 8.9.2 The Lubrizol Corporation Overview and Its Total Revenue
  • 8.9.3 The Lubrizol Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.9.4 The Lubrizol Corporation Product Description
  • 8.9.5 The Lubrizol Corporation Recent Development
• 8.10 Terumo Corporation
  • 8.10.1 Terumo Corporation Corporation Information
  • 8.10.2 Terumo Corporation Overview and Its Total Revenue
  • 8.10.3 Terumo Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.10.4 Terumo Corporation Product Description
  • 8.10.5 Terumo Corporation Recent Development

9 Production Forecasts by Regions

• 9.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)
• 9.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Production (2021-2026)
• 9.3 Key Peripheral Intervention Drug-Eluting Devices Production Regions Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan

10 Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region

• 10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.4 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.5 Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)
• 10.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
  • 11.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
• 11.3 Peripheral Intervention Drug-Eluting Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

• 12.1 Market Opportunities and Drivers
• 12.2 Market Challenges
• 12.3 Market Risks/Restraints
• 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Peripheral Intervention Drug-Eluting Devices Study

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details

Peripheral Intervention Drug-Eluting Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peripheral Intervention Drug-Eluting Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)

Segment by Application, the Peripheral Intervention Drug-Eluting Devices market is segmented into
Drug-Eluting Balloons
Drug-Eluting Stents

Regional and Country-level Analysis
The Peripheral Intervention Drug-Eluting Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peripheral Intervention Drug-Eluting Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Peripheral Intervention Drug-Eluting Devices Market Share Analysis

Peripheral Intervention Drug-Eluting Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Peripheral Intervention Drug-Eluting Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Peripheral Intervention Drug-Eluting Devices business, the date to enter into the Peripheral Intervention Drug-Eluting Devices market, Peripheral Intervention Drug-Eluting Devices product introduction, recent developments, etc.
The major vendors covered:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
Abbott
The Lubrizol Corporation